Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma
Abstract Background In hepatocellular carcinoma (HCC), pulmonary metastasis (PM) after hepatectomy is associated with poor clinical outcomes. The crucial phases of tumour cell proliferation, angiogenesis, and metastasis all entail platelet activation. In HCC, platelet distribution width (PDW) sugges...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-06-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-022-09754-3 |
| _version_ | 1818156811979587584 |
|---|---|
| author | Wen-juan Huang Guang-yu Wang Zeng-yao Liu Meng-lin Zhang Wen Wang Xin Zhang Rui-tao Wang |
| author_facet | Wen-juan Huang Guang-yu Wang Zeng-yao Liu Meng-lin Zhang Wen Wang Xin Zhang Rui-tao Wang |
| author_sort | Wen-juan Huang |
| collection | DOAJ |
| description | Abstract Background In hepatocellular carcinoma (HCC), pulmonary metastasis (PM) after hepatectomy is associated with poor clinical outcomes. The crucial phases of tumour cell proliferation, angiogenesis, and metastasis all entail platelet activation. In HCC, platelet distribution width (PDW) suggests platelet size changes and predicts a worse prognosis. The aim of this study was to assess the association between PDW and PMs in HCC patients receiving hepatectomy. Material/methods From January 2013 to December 2015, a cohort of patients who underwent hepatectomy for HCC at the Harbin Medical University Cancer Hospital in China were retrospectively evaluated. The relationship between PDW levels and clinical and demographic parameters was examined. To investigate the relationships between predicted factors and PM, a competing risk model was used. From January 2016 to December 2018, a validation cohort of 109 patients from the First Affiliated Hospital of Harbin Medical University was studied independently. Results In the primary cohort, 19 out of 214 patients had postoperative PMs. In HCC patients with PM, PDW levels were lower than in those without PM. There was a significant difference in the cumulative incidence of 2-year PM between the high-PDW and low-PDW groups after controlling for competing risk events (death prior to the development of PM) (p < 0.001). In addition, PDW was also found to be an independent predictor for PM in a multivariable competing risk analysis. The results were externally validated in another cohort. Conclusions In HCC, preoperative PDW is significantly associated with PM. PDW could be a biomarker for post-operative PM in HCC patients. |
| first_indexed | 2024-12-11T15:04:14Z |
| format | Article |
| id | doaj.art-75bd6359ab1e4f27b37393eae6cbef8c |
| institution | Directory Open Access Journal |
| issn | 1471-2407 |
| language | English |
| last_indexed | 2024-12-11T15:04:14Z |
| publishDate | 2022-06-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cancer |
| spelling | doaj.art-75bd6359ab1e4f27b37393eae6cbef8c2022-12-22T01:01:00ZengBMCBMC Cancer1471-24072022-06-012211810.1186/s12885-022-09754-3Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinomaWen-juan Huang0Guang-yu Wang1Zeng-yao Liu2Meng-lin Zhang3Wen Wang4Xin Zhang5Rui-tao Wang6Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical UniversityDepartment of Digestive Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical UniversityDepartment of Interventional Medicine, The First Affiliated Hospital, Harbin Medical UniversityDepartment of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical UniversityDepartment of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical UniversityDepartment of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical UniversityDepartment of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical UniversityAbstract Background In hepatocellular carcinoma (HCC), pulmonary metastasis (PM) after hepatectomy is associated with poor clinical outcomes. The crucial phases of tumour cell proliferation, angiogenesis, and metastasis all entail platelet activation. In HCC, platelet distribution width (PDW) suggests platelet size changes and predicts a worse prognosis. The aim of this study was to assess the association between PDW and PMs in HCC patients receiving hepatectomy. Material/methods From January 2013 to December 2015, a cohort of patients who underwent hepatectomy for HCC at the Harbin Medical University Cancer Hospital in China were retrospectively evaluated. The relationship between PDW levels and clinical and demographic parameters was examined. To investigate the relationships between predicted factors and PM, a competing risk model was used. From January 2016 to December 2018, a validation cohort of 109 patients from the First Affiliated Hospital of Harbin Medical University was studied independently. Results In the primary cohort, 19 out of 214 patients had postoperative PMs. In HCC patients with PM, PDW levels were lower than in those without PM. There was a significant difference in the cumulative incidence of 2-year PM between the high-PDW and low-PDW groups after controlling for competing risk events (death prior to the development of PM) (p < 0.001). In addition, PDW was also found to be an independent predictor for PM in a multivariable competing risk analysis. The results were externally validated in another cohort. Conclusions In HCC, preoperative PDW is significantly associated with PM. PDW could be a biomarker for post-operative PM in HCC patients.https://doi.org/10.1186/s12885-022-09754-3Hepatocellular carcinomaPulmonary metastasesPlatelet distribution widthPrognosis |
| spellingShingle | Wen-juan Huang Guang-yu Wang Zeng-yao Liu Meng-lin Zhang Wen Wang Xin Zhang Rui-tao Wang Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma BMC Cancer Hepatocellular carcinoma Pulmonary metastases Platelet distribution width Prognosis |
| title | Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma |
| title_full | Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma |
| title_fullStr | Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma |
| title_full_unstemmed | Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma |
| title_short | Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma |
| title_sort | preoperative pdw levels predict pulmonary metastasis in patients with hepatocellular carcinoma |
| topic | Hepatocellular carcinoma Pulmonary metastases Platelet distribution width Prognosis |
| url | https://doi.org/10.1186/s12885-022-09754-3 |
| work_keys_str_mv | AT wenjuanhuang preoperativepdwlevelspredictpulmonarymetastasisinpatientswithhepatocellularcarcinoma AT guangyuwang preoperativepdwlevelspredictpulmonarymetastasisinpatientswithhepatocellularcarcinoma AT zengyaoliu preoperativepdwlevelspredictpulmonarymetastasisinpatientswithhepatocellularcarcinoma AT menglinzhang preoperativepdwlevelspredictpulmonarymetastasisinpatientswithhepatocellularcarcinoma AT wenwang preoperativepdwlevelspredictpulmonarymetastasisinpatientswithhepatocellularcarcinoma AT xinzhang preoperativepdwlevelspredictpulmonarymetastasisinpatientswithhepatocellularcarcinoma AT ruitaowang preoperativepdwlevelspredictpulmonarymetastasisinpatientswithhepatocellularcarcinoma |